1. 101 GLYCEMIC, LIPID, AND ANTHROPOMETRIC MEASURES IN ELDERLY SOUTH ASIAN INDIAN IMMIGRANTS. (1st January 2005) Authors: Rosewater, I. G.; Caputo, D.; Parikh, S.; Farooki, A.; Amorosa, L. F. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0373 TREATMENT OF SLE WITH THE IMMUNOPROTEASOME INHIBITOR KZR-616: RESULTS FROM THE FIRST 4 COHORTS OF THE MISSION STUDY, AN OPEN-LABEL PHASE 1B DOSE ESCALATION TRIAL. (2nd June 2020) Authors: Furie, R.; Parikh, S.; Maiquez, A.; Khan, A.; Moreno, O.; Soneira, M.; Kirk, C.; Bomba, D.; Harvey, K.; Farmer, M. K. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Australian multicentre study of current real‐world prophylaxis practice in severe and moderate haemophilia A and B. Issue 2 (3rd January 2018) Authors: Mason, J. A.; Parikh, S.; Tran, H.; Rowell, J.; McRae, S. Journal: Haemophilia Issue: Volume 24:Issue 2(2018) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Author reply. Issue 5 (May 2015) Authors: Cromarty, J. E.; Parikh, S.; Jackson, T. J.; Lim, W. K.; Acharya, S. Journal: Internal medicine journal Issue: Volume 45:Issue 5(2015) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in weight loss‐related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin. Issue 7 (9th February 2014) Authors: Grandy, S.; Hashemi, M.; Langkilde, A.‐M.; Parikh, S.; Sjöström, C. D. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 7(2014:Jul.) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Issue 2 (29th August 2013) Authors: Wilding, J. P. H.; Woo, V.; Rohwedder, K.; Sugg, J.; Parikh, S. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time. Issue 2 (28th November 2014) Authors: Parikh, S.; Wilding, J.; Jabbour, S.; Hardy, E. Journal: International journal of clinical practice Issue: Volume 69:Issue 2(2015) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Issue 2 (29th August 2013) Authors: Bolinder, J.; Ljunggren, Ö.; Johansson, L.; Wilding, J.; Langkilde, A. M.; Sjöström, C. D.; Sugg, J.; Parikh, S. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dapagliflozin twice daily or once daily: effect on pharmacokinetics and urinary glucose excretion in healthy subjects. Issue 4 (12th January 2015) Authors: Tang, W.; Reele, S.; Hamer‐Maansson, J. E.; Parikh, S.; de Bruin, T. W. A. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 4(2015:Apr.) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes. Issue 11 (4th September 2015) Authors: Matthaei, S.; Bowering, K.; Rohwedder, K.; Sugg, J.; Parikh, S.; Johnsson, E.; on behalf of the Study 05 Group Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 11(2015:Nov.) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗